No Data
No Data
LifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and Distribution
10-Q: Q3 2024 Earnings Report
LifeMD Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency
LIFEMD INC PFD SER A 8.875% (LFMDP.US) will release its financial report after the market closes on November 7th.
$LIFEMD INC PFD SER A 8.875% (LFMDP.US) will release its financial report after the close on November 7th. How was the previous performance? $LIFEMD INC PFD SER A 8.875% (LFMDP.US) had a revenue of 50.661845 million US dollars and a net income of -6.837034 million US dollars in 2024/Q2. In 2023/Q3, the revenue was 38.613911 million US dollars, with a net income of -5.283147 million US dollars. The above data was used for the
LifeMD Launches TestoRx, a New Rex MD Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering
LIFEMD INC PFD SER A 8.875% To Go Ex-Dividend On October 4th, 2024 With 0.55469 USD Dividend Per Share
September 25th (Eastern Time) - $LIFEMD INC PFD SER A 8.875%(LFMDP.US)$ is trading ex-dividend on October 4th, 2024.Shareholders of record on October 4th, 2024 will receive 0.55469 USD dividend per
Unlock the Full List